Sharon Levy

Dr. Sharon Levy

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2014 in JAMA Pediatrics
Verified
Journal Article
Open access
PDF file
SLSharon Levy
Sharon Levy
RWRoger Weiss
Roger Weiss
LSLon Sherritt
Lon Sherritt
RZRosemary Ziemnik
Rosemary Ziemnik
ASAllegra Spalding
Allegra Spalding
LSLydia A. Shrier
Lydia A. Shrier
Substance use causes substantial morbidity and mortality among adolescents (age range, 12-17 years) and contributes to mental health disorders and negative social sequelae.1 Early initiation of substance use is also associated with increased odds of developing a substance use disorder (SUD) and experiencing substance-related problems, even as an adult.2,3 Screening adolescents for substance use and intervening immediately can reduce the burden of addiction and substance-related morbidity.1,4

1 November 2009 in Journal of Adolescent Health
Verified
Journal Article
Closed access
SLSharon Levy
Sharon Levy
LSLon Sherritt
Lon Sherritt
JGJoy Gabrielli
Joy Gabrielli
LSLydia A. Shrier
Lydia A. Shrier
JKJohn R. Knight
John R. Knight

1 April 2017 in Journal of Substance Abuse Treatment
Verified
Journal Article
Closed access
TCT. Cornelius
T. Cornelius
VEV.A. Earnshaw
V.A. Earnshaw
DMD. Menino
D. Menino
LBL.M. Bogart
L.M. Bogart
SLSharon Levy
Sharon Levy

1 February 2019 in Pediatrics
Verified
Journal Article
Open access
PDF file
SLSharon Levy
Sharon Levy
The current epidemic of opioid addiction has arguably been the most recalcitrant in the nation’s history and the first to involve substantial numbers of adolescents. The country has embarked on a public health response, including increasing access to addiction treatment. However, the treatment infrastructure, which was initially created in the 1970s, is ill equipped for meeting the needs of adolescents and young adults, who are often cared for in pediatric primary care. In this article, I review the development of the current treatment system, examine shortfalls in regard to youth-specific needs, and propose suggestions for addressing the current crisis while simultaneously preparing to address future epidemics of addiction by enabling pediatricians to better manage substance use disorders in primary care.

1 May 2023 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
SLSharon Levy
Sharon Levy
MBMelissa Brogna
Melissa Brogna
MMMachiko Minegishi
Machiko Minegishi
GSGeetha Subramaniam
Geetha Subramaniam
JMJennifer McCormack
Jennifer McCormack
EWElissa Weitzman
Elissa Weitzman
Importance: Efficient screening tools that effectively identify substance use disorders (SUDs) among youths are needed.Objective: To evaluate the psychometric properties of 3 brief substance use screening tools (Screening to Brief Intervention [S2BI]; Brief Screener for Tobacco, Alcohol, and Drugs [BSTAD]; and Tobacco, Alcohol, Prescription Medication, and Other Substances [TAPS]) with adolescents aged 12 to 17 years.Design, Setting, and Participants: This cross-sectional validation study was conducted from July 1, 2020, to February 28, 2022. Participants aged 12 to 17 years were recruited virtually and in person from 3 health care settings in Massachusetts: (1) an outpatient adolescent SUD treatment program at a pediatric hospital, (2) an adolescent medicine program at a community pediatric practice affiliated with an academic institution, and (3) 1 of 28 participating pediatric primary care practices. Participants were randomly assigned to complete 1 of the 3 electronic screening tools via self-administration, followed by a brief electronic assessment battery and a research assistant–administered diagnostic interview as the criterion standard measure for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) diagnoses of SUDs. Data were analyzed from May 31 to September 13, 2022.Main Outcomes and Measures: The main outcome was a DSM-5 diagnosis of tobacco/nicotine, alcohol, or cannabis use disorder as determined by the criterion standard World Mental Health Composite International Diagnostic Interview Substance Abuse Module. Classification accuracy of the 3 substance use screening tools was assessed by examining the agreement between the criterion, using sensitivity and specificity, based on cut points for each tool for use disorder, chosen a priori from previous studies.Results: This study included 798 adolescents, with a mean (SD) age of 14.6 (1.6) years. The majority of participants identified as female (415 [52.0%]) and were White (524 [65.7%]). High agreement between screening results and the criterion standard measure was observed, with area under the curve values ranging from 0.89 to 1 for nicotine, alcohol, and cannabis use disorders for each of the 3 screening tools.Conclusions and Relevance: These findings suggest that screening tools that use questions on past-year frequency of use are effective for identifying adolescents with SUDs. Future work could examine whether these tools have differing properties when used with different groups of adolescents in different settings.

24 May 2022 in NEJM Evidence
Verified
Journal Article
Closed access
KSKevin M. Simon
Kevin M. Simon
SLSharon Levy
Sharon Levy
OBOscar G. Bukstein
Oscar G. Bukstein
Adolescent substance use is associated with the leading causes of death in this age group: unintentional injury, suicide, and violence. This review describes the impact on neurobiological developme...